European governments recognize that the biotech industry is important to their economic development, but can the sector overcome the obstacles hindering its growth?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Anonymous. Biotechnology in Europe 2006 Comparative Study (Critical I, Banbury, UK, 2007).
Sawhney, S. & Nasto, B. Spectrum Life Sciences (Decision Resources, Waltham, MA, USA, 2002).
European Commission. Life Sciences And Biotechnology—A Strategy For Europe (EC, Belgium, 2002). <http://ec.europa.eu/biotechnology/pdf/com2002-27_en.pdf>
Brinkhorst, L.J. & Gennip, C. Life Sciences Monitor (Dutch Ministry of Economics, The Hague, 2005). <http://www.fractal.org/Life-Science-Technology/Life-Sciences-Monitor-2005.pdf>
Ketels, C. in Innovative City and Business Regions, Structural Changes in Europe 3, 56–59 (Hagbarth Publications, Bollschweil, Germany, 2004).
Anonymous. The German Biotechnology Sector (Federal Ministry for Education and Research, Bonn, 2007).
Author information
Authors and Affiliations
Supplementary information
Rights and permissions
About this article
Cite this article
Nasto, B. Chasing biotech across Europe. Nat Biotechnol 26, 283–288 (2008). https://doi.org/10.1038/nbt0308-283
Issue Date:
DOI: https://doi.org/10.1038/nbt0308-283
This article is cited by
-
Expanding YIC status
Nature Biotechnology (2008)
